Newsletter Signup | Join Community
Xgeva prevents bone complications and can delay the time to myeloma progression.
Revlimid is effective treatment for all stages of Multiple Myeloma. Understand the risk of developing a secondary cancer
Studies document the benefits—and risks of Revlimid, Ninlaro & Velcade maintenance therapy for Multiple Myeloma.
Monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma, and stage I multiple myeloma.
Kyprolis® superior to Velcade® in patients with relapsed Multiple Myeloma.
Further Findings Show Pomalyst plus Low-Dose Dexamethasone Safe and Effective in Relapsed or Refractory Multiple Myeloma
Ninlaro - effective treatment for multiple myeloma & promising for maintenance - convenient with minimal side effect
Diagnosed with Multiple Myeloma: 10 Tips on How to Get The Most From Your Doctor
Dr. Bill Benisnger M.D. of Swedish Cancer Inst. discusses the growing number of treatment options for Multiple Myeloma
ICARIA-MM trial demonstrated Isatuximab improves progression free survival in advanced Multiple Myeloma.
Has anyone elected to receive triple drug therapy and delay their ASCT? Seems like there is…
New Antibody that targets CD74 on myeloma cells gets nod from FDA to proceed. …
UK doctors identify a new target for treating Multiple Myeloma: …